Peer-influenced content. Sources you trust. No registration required. This is HCN.

Articles related to ADJUVANT TREATMENT

Journal of Clinical Oncology

Phase 2 trial in oeso-gastric adenocarcinoma (OSA) showed pathologic complete response in 59% of patients. Data update expected at ASCO 2022.

Oncology, Medical May 10th 2022

Journal of Clinical Oncology

Association of Circulating Tumor DNA Dynamics w. Clinical Outcomes in the Adjuvant Setting for Patients w. CRC from an Observational GALAXY Study in CIRCULATE – Japan

Oncology, Medical May 4th 2022

Journal of Clinical Oncology

Biomarkers for Adjuvant Endocrine and Chemotherapy in Early-Stage Breast Cancer: ASCO Guideline Update

Oncology, Medical May 4th 2022

Journal of Clinical Oncology

Use of Immune Checkpoint Inhibitor Pembrolizumab in the Treatment of High-Risk, Early-Stage Triple-Negative Breast Cancer: ASCO Guideline Rapid Recommendation Update

Oncology, Medical April 26th 2022

Journal of Clinical Oncology

Multicenter, Randomized, Phase III Trial of Short-Term Radiotherapy Plus Chemotherapy vs. Long-Term Chemoradiotherapy in Locally Advanced Rectal Cancer (STELLAR)

Oncology, Medical March 29th 2022

JAMA Network

Rates of Guideline-Concordant Surgery and Adjuvant Chemotherapy Among Patients with Early-Stage Lung Cancer in the US ALCHEMIST Study (Alliance A151216)

Oncology, Medical March 22nd 2022